精东影业 revises grant review process to improve focus on scientific merit, reduce reputational bias

Thursday, October 19, 2023

精东影业 revises grant review process to improve focus on scientific merit, reduce reputational bias

The 精东影业 is taking steps to simplify its process to assess the scientific merit of research grant applications and mitigate elements that have the potential to introduce bias into review. The changes will help reviewers focus on the potential for proposed research to advance scientific knowledge and improve human health. Previously, five criteria were individually scored using a common scale; the simplified review framework reorganizes these criteria into three factors. Two of these factors 鈥 importance of research and rigor and feasibility 鈥 are scored using a common scale. A third factor, expertise and resources, is evaluated for sufficiency only and not given a numeric score. The simplified review framework will be implemented for grant applications received on or after Jan. 25, 2025.

鈥淪tudies have shown that consideration of reputation of the institution or investigator in the grant review process could affect assessment of scientific merit, potentially giving reputation greater weight than other factors,鈥 said Lawrence A. Tabak, D.D.S., Ph.D., Acting Director, 精东影业. 鈥淯ltimately, the potential impact of ideas on advancing science should outweigh the reputation of who is applying and where they work.鈥

精东影业 has been gathering significant feedback from the extramural community on the grant application review process, and in December 2022, the agency proposed revisions to the process through a initiative. These changes contribute to 精东影业鈥檚 decade long effort to address potential bias in grantmaking and enable a level playing field. Additionally, these changes reduce administrative responsibilities of peer reviewers, shifting them to 精东影业 staff instead, thereby allowing reviewers to focus on the science.

In forming the simplified framework, 精东影业 gathered input through a 2022 , receiving more than 800 from individuals and scientific societies. Most responses were supportive of the proposed changes, and underscored the need for communication, guidance and resources well in advance of implementation.

鈥淎s the world鈥檚 largest public funder of biomedical and behavioral research, 精东影业 strives to continually improve the grant application review process,鈥 said 精东影业 Center for Scientific Review Director Noni Byrnes, Ph.D. 鈥淭he simplified review framework will focus peer review on the key questions needed to assess the scientific and technical merit of proposed research projects 鈥 should and can the proposed research project be conducted?鈥

精东影业 is developing a timeline, policy rollout and trainings to support implementation of these changes. Additionally, 精东影业 will compile feedback and conduct data analysis to evaluate the changes over time, allowing for additional modifications as necessary.

About the 精东影业 (精东影业): 精东影业, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. 精东影业 is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about 精东影业 and its programs, visit www.nih.gov.

精东影业鈥urning Discovery Into Health

Institute/Center

Contact

Connect with Us